Mitsuru Sugimoto
Overview
Explore the profile of Mitsuru Sugimoto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
94
Citations
389
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Irie H, Suzuki R, Okubo Y, Asama H, Konno N, Noguchi Y, et al.
BMC Cancer
. 2023 Apr;
23(1):316.
PMID: 37024781
Purpose: Drug-induced interstitial lung disease (ILD) is not a rare adverse event in the current chemotherapy strategy for pancreatic ductal adenocarcinoma (PDAC). Thus, we aimed to find the optimal management...
12.
Takagi T, Sugimoto M, Imamura H, Takahata Y, Nakajima Y, Suzuki R, et al.
Clin Endosc
. 2023 Jan;
56(1):107-113.
PMID: 36646425
Background/aims: Immune checkpoint blockade has recently been reported to be effective in treating microsatellite instability (MSI)-high tumors. Therefore, sufficient sampling of histological specimens is necessary in cases of unresectable pancreatic...
13.
Suzuki R, Takagi T, Sugimoto M, Sato Y, Irie H, Yomogida Y, et al.
Anticancer Res
. 2022 Dec;
42(12):5743-5750.
PMID: 36456148
Background/aim: We aimed to explore the role of intracellular C3 in pancreatic ductal adenocarcinoma (PDAC). Materials And Methods: We evaluated C3 expression in PDAC using a gene expression database and...
14.
Murakami M, Hikichi T, Nakamura J, Hashimoto M, Kato T, Kobashi R, et al.
Diagnostics (Basel)
. 2022 Oct;
12(10).
PMID: 36292169
Endoscopic submucosal dissection (ESD) in patients with early gastric cancers (EGCs) in the remnant stomach is technically difficult, owing to the limited space and fibrosis under the suture lines and...
15.
Kato T, Hikichi T, Nakamura J, Hashimoto M, Kobashi R, Yanagita T, et al.
Cancers (Basel)
. 2022 Oct;
14(19).
PMID: 36230608
Endoscopic resection is a treatment of choice for a metachronous early-stage esophageal squamous cell carcinoma (ESCC) appearing after a radical cure of esophageal cancer by chemoradiotherapy (CRT). However, non-curative resection,...
16.
Takagi T, Sugimoto M, Suzuki R, Konno N, Asama H, Sato Y, et al.
World J Gastrointest Endosc
. 2022 Oct;
14(9):536-546.
PMID: 36186943
Background: The treatment for ampullary cancer is pancreatoduodenectomy or local ampullectomy. However, effective methods for the preoperative investigation of hilar biliary invasion in ampullary cancer patients have not yet been...
17.
Sugimoto M, Suzuki R, Nozawa Y, Takagi T, Konno N, Asama H, et al.
Cancer Cell Int
. 2022 Aug;
22(1):250.
PMID: 35948981
Background: Biliary tract cancer (BTC) has a poor prognosis; therefore, useful biomarkers and treatments are needed. Serum levels of macrophage inhibitory cytokine-1 (MIC-1), a member of the TGF-β superfamily, are...
18.
Mochimaru T, Hikichi T, Hashimoto M, Nakamura J, Takasumi M, Kato T, et al.
DEN Open
. 2022 Jul;
3(1):e117.
PMID: 35898831
Endoscopic submucosal dissection (ESD) has become the standard treatment for superficial esophageal squamous cell carcinoma (SESCC). However, the treatment strategy for SESCC complicated by esophageal varices (EVs) has not been...
19.
Shimizu H, Suzuki R, Sato Y, Takagi T, Abe N, Irie H, et al.
DEN Open
. 2022 Jul;
2(1):e114.
PMID: 35873502
Pancreatic jejunostomy stricture (PJS) is one of the major late complications after pancreaticoduodenectomy. Endoscopic ultrasound-guided pancreatic drainage (EUS-PD) is considered a salvage treatment for symptomatic PJS after endoscopic retrograde pancreatography...
20.
Sugimoto M, Takagi T, Suzuki R, Konno N, Asama H, Sato Y, et al.
World J Gastroenterol
. 2022 May;
28(17):1860-1870.
PMID: 35633904
Background: Endoscopic biliary drainage using a self-expandable metallic stent (SEMS) has been widely performed to treat distal malignant biliary obstruction (DMBO). However, the optimal position of the stent remains unclear....